Výsledky vyhledávání - "Raul Urtasun"

Validation and Predictive Power of Radiation Therapy Oncology Group (RTOG) Recursive Partitioning Analysis Classes for Malignant Glioma Patients: A Report Using RTOG 90-06☆

Autor: Charles Scott, A. Jennifer Fischbach, Raul Urtasun, Benjamin Movsas, Walter J. Curran, Joseph R Simpson, Charles W. Scarantino, Christopher U Jones

Publikováno v: International Journal of Radiation OncologyBiologyPhysics. 40:51-55

Purpose: The recursive partitioning analysis (RPA) classes for malignant glioma patients were previously established using data on over 1500 patients entered on Radiation Therapy Oncology Group (RTOG) clinical trials. The purpose of the current analy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89e3637bdc9cc8e97ecd343646395af5
https://doi.org/10.1016/s0360-3016(97)00485-9

Zobrazit plný text záznamu

Changes in serial magnetic resonance spectroscopy predict outcome in high-grade glioma during and after postoperative radiotherapy

Autor: Harvey, Quon, Bryan, Brunet, Abraham, Alexander, Albert, Murtha, Bassam, Abdulkarim, Dorcas, Fulton, Marie, Smerdely, Maryann, Johnson, Raul, Urtasun, Samir, Patel, Sunita, Ghosh, Wilson, Roa

Publikováno v: Anticancer research. 31(10)

To determine any correlation between magnetic resonance spectroscopy (MRS) pattern of high-grade glioma before, during, and after radiotherapy (RT) with overall survival (OS) and progression-free survival (PFS).Twenty-six patients prospectively under

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9cbc720149b079532372aebe92c6c04d
https://pubmed.ncbi.nlm.nih.gov/21965778

Zobrazit plný text záznamu

Five-year survival after hyperfractionated radiation therapy for non-small-cell carcinoma of the lung (NSCCL): results of RTOG protocol 81-08

Autor: Raul Urtasun, T. F. Pajak, William J. Podolsky, Arnold Herskovic, James D. Cox, H. Seydel

Publikováno v: American journal of clinical oncology. 14(4)

RTOG Protocol 81-08, a feasibility study of hyperfractionated radiation therapy (HFX) with 1.2 Gy twice daily separated by 4-6 hours for non-small-cell cancer of the lung (NSCCL), was completed in 1983. Encouraging short-term results in a recently cl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e090e7c67f66dba1be8172743352add
https://pubmed.ncbi.nlm.nih.gov/1650526

Zobrazit plný text záznamu